Yüklüyor......
Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis
BACKGROUND: Patients with non‐alcoholic fatty liver disease (NAFLD), the most common cause of chronic liver disease, are at higher risk of cardiovascular disease (CVD) and associated mortality. Therefore, it is important to understand how new therapies for non‐alcoholic steatohepatitis (NASH) may im...
Kaydedildi:
| Yayımlandı: | Aliment Pharmacol Ther |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497003/ https://ncbi.nlm.nih.gov/pubmed/32638417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15935 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|